legislation: 115-s-3738

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id	congress	bill_type	bill_number	title	policy_area	introduced_date	latest_action_date	latest_action_text	origin_chamber	sponsor_name	sponsor_state	sponsor_party	sponsor_bioguide_id	cosponsor_count	summary_text	update_date	url
115-s-3738	115	s	3738	Hatch-Waxman Integrity Act of 2018	Health	2018-12-11	2018-12-11	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.	Senate	Sen. Hatch, Orrin G. [R-UT]	UT	R	H000338	1	Hatch-Waxman Integrity Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act and the Securities Exchange Act of 1934 to prevent a generic drug or biosimilar manufacturer from using a specific review process for challenging pharmaceutical drug or biologic patents.	2023-01-11T13:40:41Z

Links from other tables

2 rows from bill_id in legislation_actions
7 rows from bill_id in legislation_subjects
1 row from bill_id in legislation_cosponsors
0 rows from bill_id in cbo_cost_estimates